Fig. 7

ROC analysis and Subgroup analysis of the 31-CpG-based epigenetic signature. a Comparisons of the prognostic accuracy by the epigenetic signature (high risk vs low risk), histologic grade (III/IV vs I/II), pathologic stage (III/IV vs I/II) or the epigenetic signature and clinicopathological prognostic factor combined. b Subgroup analysis with pathologic stage of entire set. c The heatmap of the results of ssGSEA. The columns (represents ccRCC patients) were ordered from low to high based on epigenetic signature scores. d The heatmap of the CpG islands methylation level in the different tissues, cell lines